-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $292

Benzinga·08/04/2026 11:10:33
Listen to the news
Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $282 to $292.